Literature DB >> 23190062

Emergent cardiovascular risk factors in the very elderly.

Filipe A Moura1, Wladimir M Freitas, Andrei C Sposito.   

Abstract

An appreciable amount of evidence generated in the recent decades has changed the incidence and mortality of cardiovascular diseases dramatically. This advance has resulted in increased survival and, consequently, in a large new generation of very elderly individuals. In parallel, the aging of the population brought out a puzzle and a challenge for the next millennium. Despite the role of selective survival in attenuating the expression and impact of traditional risk factors, today's elderly still has a gradual increase in unstable plaque formation and, by this way, the incidence of acute cardiovascular events. Recent studies have indicated aging-related emergence of new potential modulators of atherogenesis such as cellular senescence, immunosenescence, the syndrome of frailty, sarcopenia and sirtuins. This review will focus on the most recent and relevant evidence regarding the impact of these new players on atherogenicity in the elderly.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23190062     DOI: 10.1586/erc.12.98

Source DB:  PubMed          Journal:  Expert Rev Cardiovasc Ther        ISSN: 1477-9072


  3 in total

1.  Synergistic effects of high blood cholesterol and hypertension on leukocyte and platelet recruitment in the cerebral microcirculation.

Authors:  Stephen F Rodrigues; Lidiana D Almeida-Paula; Daniel N Granger
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

2.  The prevalence of the metabolically healthy obese phenotype in an aging population and its association with subclinical cardiovascular disease: The Brazilian study on healthy aging.

Authors:  Lara Roberson; Sameer Shaharyar; Ehimen Aneni; Wladimir Freitas; Michael Blaha; Arthur Agatston; Roger Blumenthal; Raul D Santos; Hamid Feiz; Khurram Nasir; Andrei Sposito
Journal:  Diabetol Metab Syndr       Date:  2014-11-07       Impact factor: 3.320

3.  Classic cardiovascular risk factors improve in very elderly hypopituitary patients treated on standard hormone replacement in long term follow- up.

Authors:  Isabella Naves Rosa; Alexandre Anderson de Sousa Munhoz Soares; Marcelo Palmeira Rodrigues; Luciana Ansaneli Naves
Journal:  Clin Diabetes Endocrinol       Date:  2021-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.